Advanced in Contact Dermatitis

Dr. Aida Lugo

Dermatology
Office
410 Market St Ste 400, 
Chapel Hill, NC 
Advanced in Contact Dermatitis
Office
410 Market St Ste 400, 
Chapel Hill, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Aida Lugo is a Dermatologist in Chapel Hill, North Carolina. Dr. Lugo is rated as an Advanced provider by MediFind in the treatment of Contact Dermatitis. Her top areas of expertise are Contact Dermatitis, Psoriasis, Actinic Keratosis, and Epidermolysis Bullosa.

Her clinical research consists of co-authoring 27 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 11 articles and participated in 1 clinical trial in the study of Contact Dermatitis.

Graduate Institution
University Of Puerto Rico School Of Medicine
Specialties
Dermatology
Licenses
Dermatology in PR
Hospital Affiliations
Unc Hospitals
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
TeamCare
  • OTHER COMMERCIAL
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Office
410 Market St Ste 400, Chapel Hill, NC 27516
Call: 919-966-2485
Other Locations
Office
Chapel Hill, NC 27599
Call: 919-843-9447

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Vehicle-Controlled, Sample Size Adaptive Design Study to Evaluate the Safety and Efficacy of Topically Applied EB01 Cream in Healthy Adult Volunteers and Adult Subjects with Moderate to Severe Chronic Allergic Contact Dermatitis
A Randomized, Double-Blind, Vehicle-Controlled, Sample Size Adaptive Design Study to Evaluate the Safety and Efficacy of Topically Applied EB01 Cream in Healthy Adult Volunteers and Adult Subjects with Moderate to Severe Chronic Allergic Contact Dermatitis
Enrollment Status: Completed
Publish Date: November 14, 2024
Intervention Type: Drug
Study Drug: EB01 Cream
Study Phase: Phase 2
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 Years and Older) With Molluscum Contagiosum
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 Years and Older) With Molluscum Contagiosum
Enrollment Status: Completed
Publish Date: January 11, 2022
Intervention Type: Combination product
Study Phase: Phase 3
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: September 27, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: July 28, 2020
Intervention Type: Drug
Study Phase: Phase 4
A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa
A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa
Enrollment Status: Completed
Publish Date: April 09, 2020
Intervention Type: Drug
Study Phase: Phase 3
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
Enrollment Status: Terminated
Publish Date: November 05, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: December 13, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

27 Total Publications

Potential Allergens in Feminine Hygiene Products.
Potential Allergens in Feminine Hygiene Products.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: September 30, 2025
View All 27 Publications
Similar Doctors
Distinguished in Contact Dermatitis
Dr. John Cheesborough
Dermatology
Distinguished in Contact Dermatitis
Dr. John Cheesborough
Dermatology

William E. Hall MD P.A.

1911 K M Wicker Memorial Dr, 
Sanford, NC 
 (29.4 miles away)
919-775-7926
Languages Spoken:
English
See accepted insurances

John Cheesborough is a Dermatologist in Sanford, North Carolina. Dr. Cheesborough is rated as a Distinguished provider by MediFind in the treatment of Contact Dermatitis. His top areas of expertise are Actinic Keratosis, Nummular Eczema, Contact Dermatitis, and Bazex Syndrome.

Advanced in Contact Dermatitis
Dr. Ana Benitez
Dermatology
Advanced in Contact Dermatitis
Dr. Ana Benitez
Dermatology

Central Carolina Skin & Dermatology Center PA

3940 Arrowhead Blvd Ste 210, 
Mebane, NC 
 (21.2 miles away)
919-304-5900
Languages Spoken:
English
See accepted insurances

Ana Benitez is a Dermatologist in Mebane, North Carolina. Dr. Benitez is rated as a Distinguished provider by MediFind in the treatment of Contact Dermatitis. Her top areas of expertise are Sunburn, Plaque Psoriasis, Psoriasis, and Actinic Keratosis.

Advanced in Contact Dermatitis
Dr. Sanjay Tomar
Dermatology
Advanced in Contact Dermatitis
Dr. Sanjay Tomar
Dermatology

Carolina Dermatology And Endocrinology PA

244 Medspring Dr, 
Clayton, NC 
 (36.0 miles away)
919-359-0291
Languages Spoken:
English
See accepted insurances

Sanjay Tomar is a Dermatologist in Clayton, North Carolina. Dr. Tomar is rated as a Distinguished provider by MediFind in the treatment of Contact Dermatitis. His top areas of expertise are Actinic Keratosis, Basal Cell Skin Cancer, Seborrheic Keratosis, and Warts.

VIEW MORE CONTACT DERMATITIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lugo's expertise for a condition
ConditionClose
      • Advanced
      • Actinic Keratosis
        Dr. Lugo is
        Advanced
        . Learn about Actinic Keratosis.
        See more Actinic Keratosis experts
      • Contact Dermatitis
        Dr. Lugo is
        Advanced
        . Learn about Contact Dermatitis.
        See more Contact Dermatitis experts
      • Psoriasis
        Dr. Lugo is
        Advanced
        . Learn about Psoriasis.
        See more Psoriasis experts
      • Experienced
      • Acne
        Dr. Lugo is
        Experienced
        . Learn about Acne.
        See more Acne experts
      • Atopic Dermatitis
        Dr. Lugo is
        Experienced
        . Learn about Atopic Dermatitis.
        See more Atopic Dermatitis experts
      • Basal Cell Skin Cancer
        Dr. Lugo is
        Experienced
        . Learn about Basal Cell Skin Cancer.
        See more Basal Cell Skin Cancer experts
      • Cutaneous Lupus Erythematosus (CLE)
        Dr. Lugo is
        Experienced
        . Learn about Cutaneous Lupus Erythematosus (CLE).
        See more Cutaneous Lupus Erythematosus (CLE) experts
      • Dominant Dystrophic Epidermolysis Bullosa
        Dr. Lugo is
        Experienced
        . Learn about Dominant Dystrophic Epidermolysis Bullosa.
        See more Dominant Dystrophic Epidermolysis Bullosa experts
      • Dowling-Meara Epidermolysis Bullosa Simplex
        Dr. Lugo is
        Experienced
        . Learn about Dowling-Meara Epidermolysis Bullosa Simplex.
        See more Dowling-Meara Epidermolysis Bullosa Simplex experts
      View All 22 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.